{"id":12154,"date":"2022-11-09T17:44:36","date_gmt":"2022-11-09T22:44:36","guid":{"rendered":"https:\/\/aafa.org\/?post_type=asthma_medicine&p=12154"},"modified":"2026-03-23T17:19:48","modified_gmt":"2026-03-23T21:19:48","slug":"tezepelumab-ekko-tezspire","status":"publish","type":"asthma_medicine","link":"https:\/\/aafa.org\/asthma-medicine\/tezepelumab-ekko-tezspire\/","title":{"rendered":"Tezepelumab-ekko – TEZSPIRE"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”2%||2%||true|false” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” admin_label=”Page Title” module_class=”tert-content q” _builder_version=”4.17.4″ _module_preset=”default” title_font=”|600|||||||” title_text_align=”left” title_text_color=”#008c99″ title_font_size=”39px” background_enable_image=”off” background_size=”contain” background_position=”center_left” module_alignment=”left” custom_margin=”||0px||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][\/et_pb_post_title][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb2″ _builder_version=”4.18.0″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #008c99;” global_module=”1658″ global_colors_info=”{}”][\/et_pb_code][et_pb_text admin_label=”Regular Content” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ global_colors_info=”{}”]<\/p>\n

Drug Name<\/strong>: Tezepelumab-ekko<\/p>\n

Brand Name:<\/strong> TEZSPIRE\u00ae<\/a><\/p>\n

Medicine Use:<\/strong> Add-on therapy\/long-term control<\/p>\n

Type of Medicine<\/strong>: Biologic<\/p>\n

Form<\/strong>: Injection<\/p>\n

Prescribing Info<\/strong>: TEZSPIRE (tezepelumab-ekko) injection prescribing information insert<\/a>\"Download<\/p>\n

Note:<\/strong> TEZSPIRE is currently the only biologic approved by the Food and Drug Administration (FDA) for severe asthma regardless of asthma phenotype (type of asthma).<\/p>\n

Possible Side Effects:<\/strong>
Allergic reaction
Sore throat
Joint and back pain<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Tan Callout Box” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ link_line_height=”1.7em” ul_line_height=”1.7em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” background_color=”#dbdbdb” custom_padding=”4%|4%|4%|4%|true|true” hover_enabled=”0″ box_shadow_style=”preset2″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Copay Assistance Programs for TEZSPIRE<\/h3>\n

If you have commercial insurance:<\/strong>\u00a0The\u00a0TEZSPIRE Together Co-Pay Program<\/a><\/strong> can help may help you save regardless of income if you qualify. Get doses for as little as $0 and up to $100 off your in-office administration costs (pre-filled syringe only). Learn more on the TEZSPIRE Together Co-Pay Program<\/a><\/strong> website or call 888-987-7473<\/strong>.<\/p>\n

If you have government insurance:<\/strong> The TEZSPIRE Together Program<\/a><\/strong>, you may be able receive TEZSPIRE at no cost if you qualify. This includes people who:<\/p>\n